ConductScience.org, home

Paper23093229

EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?

Paliga A and 9 others. Br J Cancer, 2012. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors? Papers, record 23093229. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23093229

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?
PubMed
Journal
Br J Cancer
PubMed
Year
2012
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
1.18
iCite
Revised in PubMed
2022-03-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Paliga AA
2Onerheim RR
3Gologan AA
4Chong GG
5Spatz AA
6Niazi TT
7Garant AA
8Macheto DD
9Alcindor TT
10Vuong TT

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anus NeoplasmsMajor topic
Carcinoma, Squamous CellMajor topic
ChemoradiotherapyMajor topic
ErbB ReceptorsMajor topic
MutationMajor topic
Proto-Oncogene ProteinsMajor topic
ras ProteinsMajor topic
Adult
Aged
Aged, 80 and over
Exons
Female
Head and Neck Neoplasms
Humans
Immunohistochemistry
Male
Middle Aged
Proto-Oncogene Proteins p21(ras)
Squamous Cell Carcinoma of Head and Neck

Source PubMed

Download CSV of topics

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111597399EGFR and cancer prognosis.Eur J Cancer2001https://conductscience.org/library/papers/11597399PubMed
219519337Novel targeted radiosensitisers in cancer treatment.Curr Drug Discov Technol2009https://conductscience.org/library/papers/19519337PubMed
312499279Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.Cancer Res2002https://conductscience.org/library/papers/12499279PubMed
418337605EGFR antagonists in cancer treatment.N Engl J Med2008https://conductscience.org/library/papers/18337605PubMed
519897418Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.Lancet Oncol2010https://conductscience.org/library/papers/19897418PubMed
67968162ras mutations and expression in head and neck squamous cell carcinomas.Laryngoscope1994https://conductscience.org/library/papers/7968162PubMed
718495026High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies.BMC Cancer2008https://conductscience.org/library/papers/18495026PubMed
821772841The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case Series.J Oncol2011https://conductscience.org/library/papers/21772841PubMed
922228639Epidermal growth factor receptor protein detection in head and neck cancer patients: a many-faceted picture.Clin Cancer Res2012https://conductscience.org/library/papers/22228639PubMed
1019716155Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.Hum Pathol2009https://conductscience.org/library/papers/19716155PubMed
1117089034Is there an immunohistochemical technique definitively valid in epidermal growth factor receptor assessment?Oncol Rep2006https://conductscience.org/library/papers/17089034PubMed
1215118073Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.N Engl J Med2004https://conductscience.org/library/papers/15118073PubMed
132547513ras oncogenes in human cancer: a review.Cancer Res1989https://conductscience.org/library/papers/2547513PubMed
1421450408Chemotherapy/chemoradiation in anal cancer: a systematic review.Cancer Treat Rev2011https://conductscience.org/library/papers/21450408PubMed
158210340Increased expression of the epidermal growth factor receptor in human epidermal keratinocytes after exposure to ionizing radiation.Radiat Res1993https://conductscience.org/library/papers/8210340PubMed
1616467097Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib.Clin Cancer Res2006https://conductscience.org/library/papers/16467097PubMed
1718946061K-ras mutations and benefit from cetuximab in advanced colorectal cancer.N Engl J Med2008https://conductscience.org/library/papers/18946061PubMed
1818519948Anal cancer: the end of the road for neoadjuvant chemoradiotherapy?J Clin Oncol2008https://conductscience.org/library/papers/18519948PubMed
1917538160Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.J Clin Oncol2007https://conductscience.org/library/papers/17538160PubMed
2016648870Expression of epidermal growth factor receptor in squamous cell carcinomas of the anal canal is independent of gene amplification.Mod Pathol2006https://conductscience.org/library/papers/16648870PubMed

See all 33 referencesDownload CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
40950666Clinical immunotherapeutic significance of RAS gene mutations in melanoma.Transl Cancer Res2025https://conductscience.org/library/papers/40950666PubMed
34790403Molecular characterization of squamous cell carcinoma of the anal canal.J Gastrointest Oncol2021https://conductscience.org/library/papers/34790403PubMed
34729104A Prospective Cohort Study of Biomarkers in Squamous Cell Carcinoma of the Anal Canal (SCCAC) and their Influence on Treatment Outcomes.J Cancer2021https://conductscience.org/library/papers/34729104PubMed
34062753Research on Anal Squamous Cell Carcinoma: Systemic Therapy Strategies for Anal Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/34062753PubMed
33127962Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis.Sci Rep2020https://conductscience.org/library/papers/33127962PubMed
31851776VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02).Cancer Med2020https://conductscience.org/library/papers/31851776PubMed
30651863Expression and role of EGFR, cyclin D1 and KRAS in laryngocarcinoma tissues.Exp Ther Med2019https://conductscience.org/library/papers/30651863PubMed
30128811Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy.Med Oncol2018https://conductscience.org/library/papers/30128811PubMed
29728940Systemic Therapies for Advanced Squamous Cell Anal Cancer.Curr Oncol Rep2018https://conductscience.org/library/papers/29728940PubMed
29137429Survival rate variation with different histological subtypes of poor prognostic male anal squamous cell carcinoma: a population-based study.Oncotarget2017https://conductscience.org/library/papers/29137429PubMed
28261646Background and Current Treatment of Squamous Cell Carcinoma of the Anus.Oncol Ther2016https://conductscience.org/library/papers/28261646PubMed
28126304Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.Int J Radiat Oncol Biol Phys2017https://conductscience.org/library/papers/28126304PubMed
28068178
Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).
J Clin Oncol2017https://conductscience.org/library/papers/28068178PubMed
27937092Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial.J Clin Oncol2017https://conductscience.org/library/papers/27937092PubMed
27889034Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer.Surg Oncol Clin N Am2017https://conductscience.org/library/papers/27889034PubMed
27886225No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC).Sci Rep2016https://conductscience.org/library/papers/27886225PubMed
27219019Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection.Br J Cancer2016https://conductscience.org/library/papers/27219019PubMed
26905274Advances in the Management of Anal Cancer.Curr Oncol Rep2016https://conductscience.org/library/papers/26905274PubMed
26498363Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.Oncotarget2015https://conductscience.org/library/papers/26498363PubMed
26487956Cetuximab in combination with cisplatin and 5-Fluorouracil induces dramatic response in metastatic refractory squamous cell carcinoma of the anal canal.J Gastrointest Oncol2015https://conductscience.org/library/papers/26487956PubMed

See all 25 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ERBB32065PubTator's text mininghttps://conductscience.org/library/genes/2065NCBI Gene
ERBB42066PubTator's text mininghttps://conductscience.org/library/genes/2066NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
TXK7294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23093229

GET https://conductscience.org/api/papers/v1/23093229/references?page=2